Elevai Labs Inc
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
ELAB$1.58-1.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(Expressed in United States dollar)
| As of: | December 31, 2023 | December 31, 2022 |
|---|---|---|
| ASSETS | ||
| Current Assets | ||
| Cash | $3,326,851 | $1,154,901 |
| Receivables, net | 36,161 | 12,854 |
| Prepaids and deposits | 1,060,765 | 153,422 |
| Inventory, net | 495,667 | 230,145 |
| Total Current Assets | 4,919,444 | 1,551,322 |
| Deposit | 10,773 | 10,773 |
| Property and equipment, net | 53,119 | 53,535 |
| Operating lease right-of-use asset | 206,582 | 276,553 |
| TOTAL ASSETS | $5,189,918 | $1,892,183 |
| LIABILITIES | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | $669,375 | $244,704 |
| Customer deposits | 36,693 | 10,172 |
| Due to related parties | 77,127 | 154,325 |
| Current portion of lease liability | 145,000 | 110,616 |
| Derivative liabilities | 369,158 | 68,455 |
| Total Current Liabilities | 1,297,353 | 588,272 |
| Operating lease liability | 65,489 | 172,601 |
| TOTAL LIABILIITES | $1,362,842 | $760,873 |
| Commitments and Contingencies | ||
| EQUITY | ||
| Preferred stock $0.0001 par value; 75,000,000 stock authorized: | ||
| Series seed 1 preferred stock, Nil and 213,730 shares issued and outstanding as of December 31, 2023 and 2022, | - | 21 |
| Series seed 2 preferred stock, Nil and 3,635,252 shares issued and outstanding as of December 31, 2023 and 2022, respectively | - | 364 |
| Series A preferred stock, Nil and 1,861,799 shares issued and outstanding as of December 31, 2023, and 2022, | - | 186 |
| Common stock, $0.0001 par value, 300,000,000 shares authorized; 17,329,615 and 9,568,475 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 1,733 | 957 |
| Additional paid-in capital | 10,849,031 | 3,852,044 |
| Accumulated other comprehensive income | 202 | 111 |
| Accumulated deficit | (7,023,890) | (2,722,373) |
| TOTAL EQUITY | 3,827,076 | 1,131,310 |
| TOTAL LIABILITIES AND EQUITY | $5,189,918 | $1,892,183 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.